Exact Sciences to Participate in May Investor Conference

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

• BofA Securities Health Care Conference, Las Vegas
  Fireside chat on Wednesday, May 14, 2025 at 1:40 p.m. ET (10:40 a.m. PT)

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250502229915/en/

Derek Leckow
Exact Sciences Corp.
[email protected]
608-893-0009

Source: Exact Sciences Corp.

You May Also Be Interested In

• Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Provides New Details on Upgrading Its Robotics Strategy to the “Four-Core Full-Stack AI” and Q3 Robotics Practical Deplo
• QAIAx Clinical Trial: AGI Alternative Sentencing & Reality Pro-Social Dating (Veterans First for America)
• The 80/20 Institute Releases a 100-Day Playbook for PE-Backed CEOs Under Value-Creation Pressure